Current Practice of State-of-the-Art Coronary Revascularization in Patients with Heart Failure

Abstract The best treatment for patients with ischemic heart failure (HF) is still on debate. There is growing evidence that coronary artery bypass graft (CABG) benefits these patients. The current recommendations for revascularization in this context are that CABG is reasonable when it comes to dec...

Full description

Bibliographic Details
Main Authors: Sérgio Costa Rayol, Michel Pompeu Barros Oliveira Sá, Luiz Rafael Pereira Cavalcanti, Felipe Augusto Santos Saragiotto, Roberto Gouvea Silva Diniz, Frederico Browne Correia de Araújo e Sá, Alexandre Motta de Menezes, Ricardo Carvalho Lima
Format: Article
Language:English
Published: Sociedade Brasileira de Cirurgia Cardiovascular
Series:Brazilian Journal of Cardiovascular Surgery
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0102-76382019000100093&lng=en&tlng=en
_version_ 1828347142408765440
author Sérgio Costa Rayol
Michel Pompeu Barros Oliveira Sá
Luiz Rafael Pereira Cavalcanti
Felipe Augusto Santos Saragiotto
Roberto Gouvea Silva Diniz
Frederico Browne Correia de Araújo e Sá
Alexandre Motta de Menezes
Ricardo Carvalho Lima
author_facet Sérgio Costa Rayol
Michel Pompeu Barros Oliveira Sá
Luiz Rafael Pereira Cavalcanti
Felipe Augusto Santos Saragiotto
Roberto Gouvea Silva Diniz
Frederico Browne Correia de Araújo e Sá
Alexandre Motta de Menezes
Ricardo Carvalho Lima
author_sort Sérgio Costa Rayol
collection DOAJ
description Abstract The best treatment for patients with ischemic heart failure (HF) is still on debate. There is growing evidence that coronary artery bypass graft (CABG) benefits these patients. The current recommendations for revascularization in this context are that CABG is reasonable when it comes to decreasing morbidity and mortality rates for patients with severe left ventricular dysfunction (ejection fraction <35%), and significant coronary artery disease (CAD) and should be considered in patients with operable coronary anatomy, regardless whether or not there is a viable myocardium (class IIb). Percutaneous coronary intervention (PCI) does not have enough data to allow the panels to reach a conclusion. The Korean Acute Heart Failure registry (KorAHF) had its data released recently, showing that patients with acute HF who underwent CABG had lower death rates, more complete revascularization and less adverse outcomes compared with patients treated with PCI. Recent ESC/EACTS guidelines on myocardial revascularization clearly recommended CABG as the first choice of revascularization strategy in patients with multivessel disease and acceptable surgical risk to improve prognosis in this scenario of left ventricular dysfunction. However, a high peri-procedural risk must be compared with the benefit of late mortality, and pros and cons of each strategy (either PCI or CABG) must be weighed in the decision-making process. Spurred on by the publication of the above-mentioned article and the release of new guidelines, we went on to write an overview of the current practice of state-of-the-art coronary revascularization options in patients with HF.
first_indexed 2024-04-14T00:35:45Z
format Article
id doaj.art-595eca87377147e3a1f553674c69918b
institution Directory Open Access Journal
issn 1678-9741
language English
last_indexed 2024-04-14T00:35:45Z
publisher Sociedade Brasileira de Cirurgia Cardiovascular
record_format Article
series Brazilian Journal of Cardiovascular Surgery
spelling doaj.art-595eca87377147e3a1f553674c69918b2022-12-22T02:22:23ZengSociedade Brasileira de Cirurgia CardiovascularBrazilian Journal of Cardiovascular Surgery1678-9741341939710.21470/1678-9741-2018-0335S0102-76382019000100093Current Practice of State-of-the-Art Coronary Revascularization in Patients with Heart FailureSérgio Costa RayolMichel Pompeu Barros Oliveira SáLuiz Rafael Pereira CavalcantiFelipe Augusto Santos SaragiottoRoberto Gouvea Silva DinizFrederico Browne Correia de Araújo e SáAlexandre Motta de MenezesRicardo Carvalho LimaAbstract The best treatment for patients with ischemic heart failure (HF) is still on debate. There is growing evidence that coronary artery bypass graft (CABG) benefits these patients. The current recommendations for revascularization in this context are that CABG is reasonable when it comes to decreasing morbidity and mortality rates for patients with severe left ventricular dysfunction (ejection fraction <35%), and significant coronary artery disease (CAD) and should be considered in patients with operable coronary anatomy, regardless whether or not there is a viable myocardium (class IIb). Percutaneous coronary intervention (PCI) does not have enough data to allow the panels to reach a conclusion. The Korean Acute Heart Failure registry (KorAHF) had its data released recently, showing that patients with acute HF who underwent CABG had lower death rates, more complete revascularization and less adverse outcomes compared with patients treated with PCI. Recent ESC/EACTS guidelines on myocardial revascularization clearly recommended CABG as the first choice of revascularization strategy in patients with multivessel disease and acceptable surgical risk to improve prognosis in this scenario of left ventricular dysfunction. However, a high peri-procedural risk must be compared with the benefit of late mortality, and pros and cons of each strategy (either PCI or CABG) must be weighed in the decision-making process. Spurred on by the publication of the above-mentioned article and the release of new guidelines, we went on to write an overview of the current practice of state-of-the-art coronary revascularization options in patients with HF.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0102-76382019000100093&lng=en&tlng=enCoronary Artery BypassStentsPercutaneous Coronary InterventionHeart Failure
spellingShingle Sérgio Costa Rayol
Michel Pompeu Barros Oliveira Sá
Luiz Rafael Pereira Cavalcanti
Felipe Augusto Santos Saragiotto
Roberto Gouvea Silva Diniz
Frederico Browne Correia de Araújo e Sá
Alexandre Motta de Menezes
Ricardo Carvalho Lima
Current Practice of State-of-the-Art Coronary Revascularization in Patients with Heart Failure
Brazilian Journal of Cardiovascular Surgery
Coronary Artery Bypass
Stents
Percutaneous Coronary Intervention
Heart Failure
title Current Practice of State-of-the-Art Coronary Revascularization in Patients with Heart Failure
title_full Current Practice of State-of-the-Art Coronary Revascularization in Patients with Heart Failure
title_fullStr Current Practice of State-of-the-Art Coronary Revascularization in Patients with Heart Failure
title_full_unstemmed Current Practice of State-of-the-Art Coronary Revascularization in Patients with Heart Failure
title_short Current Practice of State-of-the-Art Coronary Revascularization in Patients with Heart Failure
title_sort current practice of state of the art coronary revascularization in patients with heart failure
topic Coronary Artery Bypass
Stents
Percutaneous Coronary Intervention
Heart Failure
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0102-76382019000100093&lng=en&tlng=en
work_keys_str_mv AT sergiocostarayol currentpracticeofstateoftheartcoronaryrevascularizationinpatientswithheartfailure
AT michelpompeubarrosoliveirasa currentpracticeofstateoftheartcoronaryrevascularizationinpatientswithheartfailure
AT luizrafaelpereiracavalcanti currentpracticeofstateoftheartcoronaryrevascularizationinpatientswithheartfailure
AT felipeaugustosantossaragiotto currentpracticeofstateoftheartcoronaryrevascularizationinpatientswithheartfailure
AT robertogouveasilvadiniz currentpracticeofstateoftheartcoronaryrevascularizationinpatientswithheartfailure
AT fredericobrownecorreiadearaujoesa currentpracticeofstateoftheartcoronaryrevascularizationinpatientswithheartfailure
AT alexandremottademenezes currentpracticeofstateoftheartcoronaryrevascularizationinpatientswithheartfailure
AT ricardocarvalholima currentpracticeofstateoftheartcoronaryrevascularizationinpatientswithheartfailure